MedTrace Logo

Controlling Antimicrobial Use Through Reducing Unnecessary Treatment of Catheter Associated Urinary Tract Infections

NCT02650518 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2016-01-08

No results posted yet for this study

Summary

Hypothesis: A short course (3-5 days) of antibiotic therapy (experimental arm) is as safe and effective as a long course of antibiotic therapy for the treatment of catheter-associated urinary tract infections.

Conditions

  • Catheter-Related Infections

Interventions

OTHER

Short-course Antibiotics

3 days of amoxicillin/clavulanate, ciprofloxacin, or cotrimoxazole.

DEVICE

Catheter Change

Urinary catheter change once randomization is complete.

Sponsors & Collaborators

  • Tan Tock Seng Hospital

    collaborator OTHER

  • Singapore General Hospital

    collaborator OTHER

  • National University of Singapore

    collaborator OTHER

  • National University Hospital, Singapore

    lead OTHER

Principal Investigators

  • Paul A Tambyah, MD · National University Hospital, Singapore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2017-10-31
Completion
2018-10-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02650518 on ClinicalTrials.gov